In the competitive landscape of global pharmaceuticals, being able to articulate a medicine’s value in a truly patient-centred way is a critical differentiator. One global organisation identified a key communication challenge within its commercial field sales teams: while they had strong clinical knowledge, they were struggling to connect emotionally with the lived experiences of patients with nasal polyps – a condition often misunderstood or downplayed as little more than a cold.
This disconnect was creating friction in customer conversations, where healthcare professionals often underestimated the impact of the condition and therefore deprioritised treatment options. Leadership also faced a second challenge: internal engagement. Teams were expressing fatigue with virtual learning solutions and a desire for live experiences that would not only re-energise them, but truly resonate.
Adding complexity, the solution needed to be flexible and scalable enough to work across multiple countries and local markets.
We developed a live, in-person immersive experience designed to bring the patient journey to life in a visceral and unforgettable way. First piloted at a global leadership meeting, the experience was anchored around a patient empathy maze that allowed participants to physically and emotionally “step into the shoes” of someone living with nasal polyps.
The experience unfolded as a journey through a series of rooms and activities designed to replicate the daily challenges patients face. From difficulty breathing and poor sleep, to the frustration of being misunderstood or dismissed by others. Participants were asked to complete everyday tasks with simulated impairments, listen to real patient stories, and reflect on the emotional toll of living with an invisible but debilitating condition.
This blend of physical simulation, narrative storytelling, and sensory immersion created a powerful and memorable learning moment. It helped internal teams move beyond data and facts to truly understand the why behind their work.
The results were immediate and profound. Participants reported a deepened sense of empathy and a stronger connection to the real-world impact of the medicines they represent. The experience not only changed how they thought about the condition, it reshaped how they approached customer conversations and patient advocacy.
Following the global meeting, the programme was rapidly adopted in four local markets, with additional rollouts already in motion. Its flexibility has allowed it to be tailored to local needs while retaining the emotional power of the core concept.
You could feel the shift in the room. For many, it was the first time they’d really understood what patients go through. It wasn’t just informative, it was transformative.
– Project Stakeholder, Global Leadership Meeting
Jump to a slide with the slide dots.
CASE STUDY (US) Building a 400+ Rep Seasonal Sales Team with Agility
Read moreSee how we helped Nissan transformed its Chairman’s Innovation Awards with inclusivity, creativity and innovation - boosting entries 900% and...
Read moreWe partnered with the R&D function of a global healthcare company to deliver a long-term engagement strategy that fits the pace, fuels the...
Read more